post-insult time of death from IgM immunocytoma post-treatment survival time from drug-treated IgM immunocytoma 2021-11-09T11:20:08Z CMO:0003867 PMID:6744286 This is a measurement of the length of time between introduction of a drug treatment protocol for an IgM immunocytoma and the death of the subject, i.e. the cessation of all vital functions of the body including the heartbeat, brain activity (including the brain stem), and breathing. clinical_measurement_ontology slaulede